Transdiagnostic cognitive behavioural treatment and the impact of co-morbidity

an open trial in a cohort of primary care patients

Hafrún Kristjánsdóttir, Paul M. Salkovskis, Baldur Heidar Sigurdsson, Engilbert Sigurdsson, Agnes Agnarsdóttir, Jón Fridrik Sigurdsson

Research output: Contribution to journalArticle

8 Citations (Scopus)
160 Downloads (Pure)

Abstract

Background: The development of initiatives to improve access to psychological therapies has been driven by the realization that untreated anxiety and depression are both very common and costly to individuals as well as society. Effective and efficient treatments, mostly in the form of cognitive behavioural therapies (CBT), can be used in ways which enhance their acceptability and accessibility. To date, numbers of group therapies have been developed to improve cost efficiency, but in spite of growing interest in transdiagnostic approaches, group therapies have so far mostly been diagnosis specific. Aims: This study is aimed at evaluating a brief transdiagnostic cognitive behavioural group therapy (TCBGT) designed to treat both anxiety and depression among patients in primary care. Method: The participants were 287 adult patients in primary care with diagnoses of depression and/or anxiety disorders. They underwent a 5-week TCBGT. A mixed design ANOVA was used to evaluate differential effects of treatment according to diagnostic groups (anxiety versus depression) and number of diagnoses (co-morbidity). Results: Pre–post differences were significant and the treatment was equally effective for both anxiety disorders and depression. Number of diagnoses did not affect the outcome. Conclusions: The study indicates feasibility of the brief transdiagnostic group therapy for a wide range of mood and anxiety disorders in primary care. The results indicate that low intensity, brief transdiagnostic group therapies may be a feasible way to improve access to psychological therapies for a large number of patients.
Original languageEnglish
Pages (from-to)215-223
JournalNordic Journal of Psychiatry
Volume70
Issue number3
Early online date24 Sep 2015
DOIs
Publication statusPublished - 2016

Fingerprint

Group Psychotherapy
Primary Health Care
Morbidity
Depression
Cognitive Therapy
Anxiety Disorders
Anxiety
Therapeutics
Psychology
Feasibility Studies
Mood Disorders
Analysis of Variance
Costs and Cost Analysis

Cite this

Transdiagnostic cognitive behavioural treatment and the impact of co-morbidity : an open trial in a cohort of primary care patients. / Kristjánsdóttir, Hafrún; Salkovskis, Paul M.; Sigurdsson, Baldur Heidar; Sigurdsson, Engilbert; Agnarsdóttir, Agnes; Sigurdsson, Jón Fridrik.

In: Nordic Journal of Psychiatry, Vol. 70, No. 3, 2016, p. 215-223.

Research output: Contribution to journalArticle

Kristjánsdóttir, Hafrún ; Salkovskis, Paul M. ; Sigurdsson, Baldur Heidar ; Sigurdsson, Engilbert ; Agnarsdóttir, Agnes ; Sigurdsson, Jón Fridrik. / Transdiagnostic cognitive behavioural treatment and the impact of co-morbidity : an open trial in a cohort of primary care patients. In: Nordic Journal of Psychiatry. 2016 ; Vol. 70, No. 3. pp. 215-223.
@article{af09778cc3684e689d67debcb8c5f613,
title = "Transdiagnostic cognitive behavioural treatment and the impact of co-morbidity: an open trial in a cohort of primary care patients",
abstract = "Background: The development of initiatives to improve access to psychological therapies has been driven by the realization that untreated anxiety and depression are both very common and costly to individuals as well as society. Effective and efficient treatments, mostly in the form of cognitive behavioural therapies (CBT), can be used in ways which enhance their acceptability and accessibility. To date, numbers of group therapies have been developed to improve cost efficiency, but in spite of growing interest in transdiagnostic approaches, group therapies have so far mostly been diagnosis specific. Aims: This study is aimed at evaluating a brief transdiagnostic cognitive behavioural group therapy (TCBGT) designed to treat both anxiety and depression among patients in primary care. Method: The participants were 287 adult patients in primary care with diagnoses of depression and/or anxiety disorders. They underwent a 5-week TCBGT. A mixed design ANOVA was used to evaluate differential effects of treatment according to diagnostic groups (anxiety versus depression) and number of diagnoses (co-morbidity). Results: Pre–post differences were significant and the treatment was equally effective for both anxiety disorders and depression. Number of diagnoses did not affect the outcome. Conclusions: The study indicates feasibility of the brief transdiagnostic group therapy for a wide range of mood and anxiety disorders in primary care. The results indicate that low intensity, brief transdiagnostic group therapies may be a feasible way to improve access to psychological therapies for a large number of patients.",
author = "Hafr{\'u}n Kristj{\'a}nsd{\'o}ttir and Salkovskis, {Paul M.} and Sigurdsson, {Baldur Heidar} and Engilbert Sigurdsson and Agnes Agnarsd{\'o}ttir and Sigurdsson, {J{\'o}n Fridrik}",
year = "2016",
doi = "10.3109/08039488.2015.1081404",
language = "English",
volume = "70",
pages = "215--223",
journal = "Nordic Journal of Psychiatry",
issn = "0803-9488",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Transdiagnostic cognitive behavioural treatment and the impact of co-morbidity

T2 - an open trial in a cohort of primary care patients

AU - Kristjánsdóttir, Hafrún

AU - Salkovskis, Paul M.

AU - Sigurdsson, Baldur Heidar

AU - Sigurdsson, Engilbert

AU - Agnarsdóttir, Agnes

AU - Sigurdsson, Jón Fridrik

PY - 2016

Y1 - 2016

N2 - Background: The development of initiatives to improve access to psychological therapies has been driven by the realization that untreated anxiety and depression are both very common and costly to individuals as well as society. Effective and efficient treatments, mostly in the form of cognitive behavioural therapies (CBT), can be used in ways which enhance their acceptability and accessibility. To date, numbers of group therapies have been developed to improve cost efficiency, but in spite of growing interest in transdiagnostic approaches, group therapies have so far mostly been diagnosis specific. Aims: This study is aimed at evaluating a brief transdiagnostic cognitive behavioural group therapy (TCBGT) designed to treat both anxiety and depression among patients in primary care. Method: The participants were 287 adult patients in primary care with diagnoses of depression and/or anxiety disorders. They underwent a 5-week TCBGT. A mixed design ANOVA was used to evaluate differential effects of treatment according to diagnostic groups (anxiety versus depression) and number of diagnoses (co-morbidity). Results: Pre–post differences were significant and the treatment was equally effective for both anxiety disorders and depression. Number of diagnoses did not affect the outcome. Conclusions: The study indicates feasibility of the brief transdiagnostic group therapy for a wide range of mood and anxiety disorders in primary care. The results indicate that low intensity, brief transdiagnostic group therapies may be a feasible way to improve access to psychological therapies for a large number of patients.

AB - Background: The development of initiatives to improve access to psychological therapies has been driven by the realization that untreated anxiety and depression are both very common and costly to individuals as well as society. Effective and efficient treatments, mostly in the form of cognitive behavioural therapies (CBT), can be used in ways which enhance their acceptability and accessibility. To date, numbers of group therapies have been developed to improve cost efficiency, but in spite of growing interest in transdiagnostic approaches, group therapies have so far mostly been diagnosis specific. Aims: This study is aimed at evaluating a brief transdiagnostic cognitive behavioural group therapy (TCBGT) designed to treat both anxiety and depression among patients in primary care. Method: The participants were 287 adult patients in primary care with diagnoses of depression and/or anxiety disorders. They underwent a 5-week TCBGT. A mixed design ANOVA was used to evaluate differential effects of treatment according to diagnostic groups (anxiety versus depression) and number of diagnoses (co-morbidity). Results: Pre–post differences were significant and the treatment was equally effective for both anxiety disorders and depression. Number of diagnoses did not affect the outcome. Conclusions: The study indicates feasibility of the brief transdiagnostic group therapy for a wide range of mood and anxiety disorders in primary care. The results indicate that low intensity, brief transdiagnostic group therapies may be a feasible way to improve access to psychological therapies for a large number of patients.

UR - http://dx.doi.org/10.3109/08039488.2015.1081404

UR - http://www.tandfonline.com/doi/full/10.3109/08039488.2015.1081404

U2 - 10.3109/08039488.2015.1081404

DO - 10.3109/08039488.2015.1081404

M3 - Article

VL - 70

SP - 215

EP - 223

JO - Nordic Journal of Psychiatry

JF - Nordic Journal of Psychiatry

SN - 0803-9488

IS - 3

ER -